A New York investor rights firm is examining whether Barclays PLC misled shareholders, a probe triggered by the bank's 600 million pound ($809.7 million) exposure to a collapsed UK mortgage lender that surfaced in late February. Rosen Law Firm said it is preparing a class action seeking recovery of investor losses, with affected shareholders eligible for compensation through a contingency fee arrangement that carries no out-of-pocket costs.
"Barclays may have issued materially misleading business information to the investing public," the firm said in a statement dated Sept. 2, urging investors who purchased Barclays securities to contact it about their legal rights.
The investigation stems from a Reuters report published Feb. 27 detailing how lenders were "rocked by the implosion of little-known UK mortgage provider Market Financial Solutions Ltd," reviving warnings of more "cockroaches" in the booming private credit industry. The article cited another publication reporting Barclays' 600 million pound exposure to MFS. Barclays American Depositary Shares fell 3.99 percent on Feb. 27 and a further 2.3 percent on March 2 as the news rippled through markets.
The probe adds to legal and reputational pressure on one of Britain's largest banks at a time when private credit has become a focal point of investor scrutiny. Market Financial Solutions' collapse in late February raised broader questions about hidden leverage across the sector, with analysts warning that other lenders could hold similar undisclosed positions. For Barclays shareholders, the stakes extend beyond the immediate share-price decline: a successful securities claim could expose the bank to damages tied to the period when the alleged misleading disclosures were made, while regulatory follow-up in either the UK or US could compound the financial hit.
Rosen Law Firm, which says it has recovered billions of dollars for investors and ranked No. 1 by ISS Securities Class Action Services for settlements in 2017, is among the most active plaintiffs' firms pursuing securities litigation. The investigation remains at an early stage, with no formal complaint yet filed. Investors who purchased Barclays securities have until the court-appointed deadline to seek lead plaintiff status, a window that typically opens once a class action is filed. Barclays has not publicly responded to the investigation, and the firm's notice carries the standard disclaimer that prior results do not guarantee a similar outcome.
This article is for informational purposes only and does not constitute investment advice.